NEW YORK, January 20, 2011: Today, Perrigo Company (Nasdaq: PRGO;TASE), a global healthcare products supplier, announced that it would acquire nearly all of the assets of Paddock Laboratories, Inc. for $540 million in cash. Pending regulatory approval, the transaction is expected to close at the end of the fourth quarter. Morgan Lewis represented Perrigo on the transaction.
The Morgan Lewis team consisted of Business and Finance partner Robert Robison, Antitrust partners Harry Robins and Scott Stempel, FDA & Healthcare partner Phoebe Mounts, Tax partner Kenneth Kail, and associates Gregory Louis, Lynda Madera Vaillant, and Sheryl Orr.
For more information about the transaction, please see Perrigo's press release.